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Bacteriocins are ribosomally synthesized antimicrobial peptides displaying 
different mode of action. Non pathogenic Bacillus licheniformis are usually 
associated with plants and produce several bacteriocins. This work looks at 
drug designing strategies using protein modelling and bioinformatics tools.  In 
this study computational modelling and docking studies were carried out using 
the 13 amino acid sequence of a previously characterized thermostable 
bacteriocin, BL8 produced by B. licheniformis strain BTHT8. These analyses 
enabled the understanding of the structure of BL8 protein domain, which was 
noted to belong to alpha + beta protein fold family. In addition, the docking 
study predicted that BL8 has properties of angiotensin-converting enzyme 
(ACE) inhibitor.   
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1. INTRODUCTION 
Bacteriocins produced by microorganisms belonging to different eubacterial taxonomic branches 
exhibit bactericidal activity against closely related bacteria. Being heterogeneous compounds, they display 
variable molecular weights, biochemical properties, inhibitory spectra and mechanisms of action [1]. 
Bacillus licheniformis are non-pathogenic soil organisms mainly associated with plant and plant 
materials in nature, but can be isolated from nearly everywhere because of the dissemination of their highly 
resistant endospores with dust [2]. They also produce several bacteriocins [3, 4, 5]. 
Numerous online servers and tools predict 3D structure of proteins, while some others provide precise 
information on proteins interactions and their localization in stable conformation [6]. Modelling is the most 
common protein structure prediction methods in structural genomics and proteomics [7]. Computational biology 
and bioinformatics have the potential of speeding up drug discovery process thus reducing costs, and also 
changing the way drugs are designed [8]. One such method is the docking of the drug molecule with the 
receptor (target). The site of drug action ultimately responsible for the pharmaceutical effect is important in 
molecular modelling. Docking predicts the preferred orientation of one molecule to a second when bound to 
each other to form a stable complex. Knowledge of the preferred orientation may therefore be used to predict the 
strength of association or binding affinity between two molecules. Docking predicts the binding orientation of 
small molecule- drug candidates to their protein targets, in order to predict the affinity and activity of the same 
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[9]. The protein sequence available in the BIOPEP database can thus be evaluated as a good/bad precursor of 
peptides with biological activity as activity depends on amino acid composition and structure. 
Angiotensin-I-converting enzyme (EC 3.4.15.1; ACE) was originally isolated from horse blood in 1956 
as a hypertension-converting enzyme and plays a crucial role in regulating blood pressure by not only 
converting angiotensin-I to the potent vasoconstrictor angiotensin-II, but also by inactivating the vasodilator, 
bradykinin. Angiotensin-II causes the release of a sodium retaining steroid, aldosterone from the adrenal cortex, 
which increases blood pressure. Inhibition of ACE is a useful therapeutic approach in the treatment of 
hypertension. Search for natural ACE inhibitors as alternatives to synthetic ones is of great interest for safe and 
economical use as pharmaceuticals. Naturally occurring peptides with ACE- inhibitory activity were first 
obtained from snake venom. Oshima et al. [10] reported the first ACE inhibitory peptides produced from food 
proteins by digestive proteases. Many marine-derived antihypertensive peptides had potent ACE inhibition 
activities [11]. These inhibitors bind to the active site or to the inhibitor binding site that is remote from the 
active site to alter enzyme conformation such that, the substrate no longer binds to the active site. Inhibitors of 
ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy. 
Thus, here we tried to find the binding affinity of peptide BL8 which could go on to be a lead 
molecule. BL8 is a novel previously characterized 13 amino acid, thermostable peptide bacteriocin from 
Bacillus licheniformis BTHT8 isolated from marine sediment [2]. The aim of the present study was to perform 
computational sequence analysis and 3D structural modelling using this 13 amino acid sequence of BL8. A 
computational approach could be helpful in finding some structural requirements for peptides, to be designated 
as biologically active (bioactive) [12]. 
2. RESEARCH METHOD  
BL8 sequence: NH2-Ser-Trp-Ser-Cys-Cys-Gly-Asn-Cys-Ser-Ile-Ser-Gly-Ser-COOH2 was used in the 
analysis.  
2.1 Protein sequence and structure analysis 
Various bonding interactions between the side chains on the amino acid residues are used to determine 
the tertiary structure of the protein. I-TASSER server was used for modelling. I-TASSER simulations generate a 
large ensemble of structural conformations for each target called as decoys. For the selection of final model, I-
TASSER [13], used the SPICKER program to cluster all the decoys based on pairwise structure similarity, 
reporting five models corresponding to the five largest structure clusters [14]. The confidence of each model is 
quantitatively measured by C-score that can be calculated based on the significance of threading template 
alignments and the convergence parameters of the structure assembly simulations. 
2.1 Screening of bacteriocin BL8 for biological activity 
A database of potential biologically active peptide sequences, named BIOPEP 
(http://www.uwm.edu.pl/biochemia) was used to screen the protein BL8 for its potential biological activity. 
2.3 Preparation for Docking 
Based on leads obtained from BIOPEP, the crystal structure of human angiotensin converting enzyme 
(PDB ID: 1O86) was downloaded from the database Protein Data Bank (PDB) (http://www.rcsb.org/ 
pdb/home/home.do)15. 
2.3.1Models predicted by I-TASSER 
The model of the bacteriocin BL8 with the least C-score provided by I-TASSER server was used as the 
ligand for docking. 
2.3.2 Docking and visualization 
For docking, we used 1O8A (PDB), a crystal structure of human ACE bound to lisinopril (ACE-
inhibitory drug). A binding site with a radius of 15 A˚ and coordinates x: 41.268, y: 34.559 and z: 45.393 was 
created by the removal of lisinopril from ACE structure. Automated molecular docking was performed using the 
ZDOCK. ZDOCK is a rigid-body protein-protein docking algorithm based on the Fast Fourier Transform 
correlation technique that is used to explore the rotational and translational space of a protein-protein system 
[16]. Evaluation of the molecular docking was performed according to the scores and binding energy values in 
order to obtain the best peptide poses. All obtained conformations of protein - ligand complexes were analyzed 
for the interactions (the hydrophobic, hydrophilic, electrostatic, and coordination interactions) and binding 
energy of the docked structure using BIOVIA Discovery Studio Visualizer version 16.1.0. 
3. RESULTS AND ANALYSIS  
Bacillus licheniformis BTHT8 produced the thermostable bacteriocin BL8whose sequence was 
revealed using N-terminal sequencing. This small peptides’ 13 amino acid sequence stretch is: NH2-Ser-Trp-
Ser-Cys-Cys-Gly-Asn-Cys-Ser-Ile-Ser-Gly-Ser-COOH [2] (SWSCCGNCSISGS). The novelty of this small 
peptide BL8 was disclosed when it was proved that the N-terminal amino acid sequences of BL8 showed no 
significant similarity with the sequences of bacteriocins of other Bacillus sp. The sequences also did not show 
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similarity when compared with bacteriocins from other organisms by BLAST in protein database of NCBI2. 
Therefore considering the novelty of the sequences, it was used for modelling and docking studies, to 
understand whether this peptide has other biochemical properties. 
3.1.  Modelling 
The 13 amino acid sequence was modelled to predict its structure (Fig. 1). For each target, I-TASSER 
simulations generated a large ensemble of structural conformations called decoys. To select the final models, I-
TASSER used the SPICKER program to cluster all the decoys based on the pair-wise structure similarity, and 
reported up to five models corresponding to the five largest structure clusters. C-score was typically in the range 
of [-5, 2], where a C-score of a higher value signifies a model with a higher confidence and vice-versa [17]. 
 
Fig. 1.   Models of BL8 as predicted by I-TASSER : A) Model 1, B) Model 2 , C) Model 3, D) Model 4, E) 
Model 5 ; with C-score values as follows :   -0.94, -1.22, -2.35, -2.64, -1.31 respectively. Model A with the 
highest C-score was considered as the best model. 
3.2.  Screening of protein BL8 for biological activity 
 BIOPEP revealed the potential biological activity of BL8. The frequency of the occurrence of fragments with 
the activity for the analyzed sequence is shown in figure 2. The analyzed peptide revealed the potential 
inhibitory activity on angiotensin-converting enzyme (ACE), i.e. its biological activity as an Angiotensin-
converting enzyme inhibitor (ACE inhibitor). Through the use of BIOPEP server, the protein sequence of BL8 
could be evaluated as a good/bad precursor of peptides with its biological activity showing it to be ACE 
inhibitor [18]. 
 
Fig.  2. Frequency of occurrence of ACE inhibitory activity in BL8 sequence. 
3.3 Docking studies 
Contributors have to pay the following additional cost Since the biological function of the 13 amino 
acid peptide BL8 was shown to be Angiotensin-converting enzyme inhibitor (ACE inhibitor), it was necessary 
to understand the interaction of this peptide with ACE. Hence, in this study the docking interaction was 
performed between the receptor ACE (PDB ID 1O86) and ligand BL8 protein, using ZDOCK version, 3.0.2. 
[16]. This helped us to understand and explore their binding modes.  
Knowledge of Angiotensin-converting enzyme (ACE) structure is essential for understanding as well 
as elucidation of the mechanism of action underlying the pharmacological and toxicological action of these 
agents for rational drug design. Somatic angiotensin-converting enzyme (ACE) contains two homologous 
domains (ACEN and ACEC), each bearing a functional active site [19] ACE possesses a catalytic zinc site which 
usually coordinates with nitrogen, oxygen and sulphur donors of His, Glu, Asp and Cys residues while His is 
most frequently encountered in the coordination sphere of zinc metal ion [20]. 36-residue synthetic peptides 
represent the ACEN [His361-Ala396] and ACEC [His959-Ala994] zinc binding sequences. 
ZDOCK predicted several protein (ACE) – ligand (BL8) complexes of which, complexes I showed 
maximum favoured interactions. In complex I, the ligand interacting atoms of ACE comprised those of amino 
acid residues such as: Thr 92, Glu 403, Phe 512, His 513, Val 518, Tyr 135, Asn 136, Arg 124, Lys 118, Ile 88, 
Tyr 62, Trp 59, Tyr 360, Ala 63, Arg 402, Asn 66, Trp 357, His 353, Tyr 523, His 410, His 387, Glu 384, Ser 
512 (Fig. 3). As most of the amino acid residues in the active site are hydrophobic, they were the major 
contributors to the receptor-ligand interaction [3]. 
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Fig. 3. Docked conformation of A) ACE-BL8 complex-I. The yellow ribbon structures indicate Angiotensin-
converting enzyme (receptor) and the red space filling model indicates BL8 (Inhibitor) B) A close view of the 
different interactions involved in the complex. The red stick model indicates the inhibitor BL8 and the labelled 
amino acids are of the receptor protein 
The amino acids involved in the binding pocket of 1O86 which binds to lisinopril, an ACE inhibitor, 
included Glu 384, His 353, Ala 354, Tyr 523, Tyr 520, Lys 511 [21]. Thus we can observe that both lisinopril 
and bacteriocin BL8 commonly bind to two amino acids in the binding site of ACE – His 353 and Glu 384, 
which once again adds to the substantiation that BL8 is an ACE inhibitor.  
Protein–protein interactions are essential to cellular and immune function, and in many cases, in the 
absence of an experimentally determined structure of the complex, these interactions must necessarily be 
modelled for an understanding of their molecular basis [22]. The protein docking server ZDOCK, uses the rigid-
body docking programs to predict the structures of protein–protein complexes [23]. This not only provides users 
with an accessible and intuitive interface, but also provides the options to guide the scoring and the selection of 
output models, in addition to dynamic visualization of input structures by BIOVIA Discovery Studio [24]. In 
this study, the C-value of the model protein BL8 was sufficient to provide the relevant information necessary for 
peptide design. 
The amine group of the N-terminal Cysteine residue of BL8 established hydrogen bonds with the 
carboxylic group of Glu384 (Table 1, Appendix A). H-bond interactions established with Glu384 and Ser13 
presented more potent interactions, which greatly contributed to stabilization [25]. This study thus provides 
inklings to the possible biological functions of BL8, which will be substantiated by other experiments. Thus 
application of bioinformatic tools enables the research community to easily and quickly produce structural 
models of protein–protein complexes and symmetric multimers for their own analysis leading to the Drug 
Discovery processes22. 
4. CONCLUSION 
In this manuscript, we describe the extent to which Bioinformatic tools can be utilised in case of a 
protein whose atomic structure is still not solved and whose function is yet to be extensively investigated. We 
predicted distinguished features as well as the secondary structure of BL8, in addition to other structural features 
with neural networks-based methods. It was interesting to note that all the different prediction tools used here, 
with either the sequence or the structure as inputs, were in consensus in the results generated. This lends greater 
confidence in the approach used. An approach is taken towards the prediction of the most plausible protein-
ligand complex from the complexes generated and in the event of little or no information available for the 
interface of the two binding partners. Structurally, BL8 protein domain seems to belong to alpha + beta protein 
fold family, whereas its interacting partner, ACE is an elongated all-beta structure. The question of the accuracy 
of complex prediction remains dependent on the experimental verification. On the whole our data and analysis 
supported the view that drug design can be aided by Bioinformatics tools and by protein modeling. In our study, 
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the E-value of the model was sufficient to provide the relevant information necessary for peptide design. This 
helps to save time and eliminate enormous costs due to random routine functional screens, making drug 
discovery and design easier. 
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SUPPLEMENTARY FILES 
 Table 1: Interaction table showing the interaction of the amino acids of ACE protein with the 
bacteriocin protein BL8. (Complex 1) 
Interacting residues Distance Bond 
A:SER1:N- A:GLU403:OE1 
A:ASN66:ND2 - A:CYS8:O 
A:ASN70:ND2-A:SER9:OG 
A:THR92:OG1-A:SER13:OG 
A:ALA356:N - A:CYS5:SG 
A:ALA356:N - A:CYS8:SG 
A:TRP2:N - A:GLU403:OE1 
A:CYS4:N - A:SER1:O 
A:CYS5:N - A:CYS8:SG 
A:CYS5:SG- A:GLU384:OE1 
A:CYS5:SG - A:SER3:O 
A:GLY6:N - A:CYS4:O 
A:ASN7:ND2-A:ASN70:OD1 
A:CYS8:N - A:CYS4:SG 
A:CYS8:SG - A:ALA356:O 
A:CYS8:SG - A:SER3:O 
A:SER9:N - A:ASN7:OD1 
A:SER9:OG - A:ASN7:OD1 
A:SER11:OG - A:SER13:O 
A:SER13:N - A:SER11:OG 
A:HIS353:CD2 - A:CYS5:O 
A:SER355:CB - A:CYS5:O 
A:SER516:CB - A:GLY6:O 
A:GLU403:OE2 - A:TRP2 
A:GLU403:OE2 - A:TRP2 
A:GLY12:N - A:TRP2 
A:CYS8:SG - A:TRP357 
A:ALA63 - A:ILE10 
A:ALA356 - A:CYS5 
A:CYS4 - A:VAL518 
A:CYS4 - A:CYS8 
A:CYS5 - A:CYS8 
A:CYS8 - A:ILE10 
A:TRP357 - A:ILE10 
A:TRP357 - A:CYS8 
A:HIS387 - A:CYS5 
 
2.51279 
3.19107 
2.58521 
2.29898 
2.72172 
3.75053 
2.18004 
3.0957 
3.18924 
2.57598 
3.35831 
2.82362 
3.22574 
3.33851 
2.46252 
3.45126 
2.97575 
2.71684 
2.9139 
3.01142 
3.20681 
3.53277 
3.09963 
3.09448 
4.01947 
3.76758 
4.27101 
3.76191 
4.48997 
4.64264 
4.23183 
4.58299 
5.32705 
5.09342 
4.83437 
4.79971 
 
Electrostatic 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Hydrogen Bond 
Electrostatic 
Electrostatic 
Hydrogen Bond 
Other 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
Hydrophobic 
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